Recommended videos you might also like
11:47
CX DEBATE: Types A and B terms are no longer satisfactory - For the motion
![](https://reachora-public-videos.imgix.net/v/10/4/7/45648b-c8ea-4c1a-948b-fcdbe231e93a/thumbnails/image_1.jpg)
07:57
WHEN TO INTERVENE - threshold of intervention - a disease specific approach f...
![](https://reachora-public-videos.imgix.net/v/10/6/e/db4e01-98c9-4b36-80c9-a8c04a5bd021/thumbnails/image_1.jpg)
07:38
My way to do FEVAR for optimal results
![](https://reachora-public-videos.imgix.net/v/10/4/e/ff6495-576a-4408-b80a-9585ebdbfab0/thumbnails/image_1.jpg)
07:39
Endovascular repair in patients with connective tissue disorders-thoracoabdom...
![](https://reachora-public-videos.imgix.net/v/10/5/8/566298-a8a9-44bf-a845-6d4953c87a2f/thumbnails/image_1.jpg)
07:53
Impact of type IIIa and IIIb endoleaks in durability
![](https://reachora-public-videos.imgix.net/v/10/2/0/e73d10-b907-4997-9fae-7fe0cd67c82e/thumbnails/image_1.jpg)
07:39
By a translumbar approach
![](https://reachora-public-videos.imgix.net/v/10/8/c/d58930-f353-4942-b656-a6596b120384/thumbnails/image_1.jpg)
STEP findings
10 views
Uploaded on Aug 30, 2018
Join the conversation
to comment